High level expression of full-length LOXL2, as well as its L2Δ13 isoform, promotes cell migration and invasion of esophageal cancer cells in vitro and in vivo, which is further linked to tumor metastasis and poor clinical outcome of esophageal cancer patients [16,21]. The gene discussed is LOXL2; the disease is neoplasm.